Cell-Death Receptor Links Cancer Susceptibility and Inflammation

When intact, TRAIL and its receptor decrease the influx of inflammatory cells and molecules that can lead to cancer. New models of cancer have suggested a link between inflammation and cancer in the last five years, and El-Deiry is in the early stages of trying to understand this connection with respect to the TRAIL pathway.

El-Deiry and his team are now looking within tumor tissue for inflammatory molecules as clues to how cancer and inflammation are coupled. “Our work with TRAIL and its receptor in mouse models represents a new way to look at cancer susceptibility and its potential therapy in humans as well as new ways to decrease debilitating radiation side-effects experienced by cancer patients,” says El-Deiry.

Read more about this Cancer Susceptibility and Inflammation study.

Home Men's Health Women's Health Senior's Health My Recommendation Tinnitus
Anti-Aging Beauty Health & Longevity Sports Nutrition Hyaluronic Acid AHCC Avemar